<DOC>
	<DOCNO>NCT01911871</DOCNO>
	<brief_summary>The investigator ' primary objective study prevalence myocardial iron overload , define cardiac T2* &lt; 20 m , 3 population multiply transfuse patient , affect thalassemia , sickle cell disease , myelodysplasia .</brief_summary>
	<brief_title>Multicenter Observational Study Myocardial Iron Overload 3 Multitransfused Populations</brief_title>
	<detailed_description>The inevestigators ' primary objective study prevalence myocardial iron overload , define cardiac T2* &lt; 20 m , 3 population multiply transfuse patient , affect thalassemia , sickle cell disease , myelodysplasia . The investigator record concomitantly parameter , accord literature data , may influence occurrence complication , look correlation parameter iron overload ( secondary objective ) , 3 cohort . 14 centre involve enrol patient thalassemia , sickle cell disease , myelodysplasia receive past year &gt; 8 erythrocyte concentrate , cardiac MRI . Patients file register type disease , age begin transfusion chelation , chelator type dosage , liver cardiac T2* .</detailed_description>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>Iron Overload</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<criteria>Thalassemia , sickle cell disease , myelodysplasia receive past year &gt; 8 erythrocyte concentrate &gt; 6 year age preexist cardiac disease</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Thalassemia</keyword>
	<keyword>sickle cell disease</keyword>
	<keyword>myelodysplasia</keyword>
	<keyword>transfusion</keyword>
	<keyword>chelation</keyword>
</DOC>